STEX stock forecast, quote, news & analysis
Streamex Corp is a vertically integrated technology and infrastructure company... Show more
Why Streamex Corp. (STEX) Stock Is Down -47% in the Last 30 Days
Key Takeaways
- Streamex Corp. (STEX) shares fell roughly 47% over the 30 days through the latest close, extending a sustained multi-month decline.
- The move reflects persistent selling pressure tied to a small revenue base, recurring losses, and dilution and going-concern concerns disclosed in company filings.
- Over the most recent quarter, the stock declined approximately 42%, continuing a downtrend from its 52-week high.
- Streamex is pivoting toward tokenized real-world assets, anchored by its gold-backed, yield-bearing GLDY product, alongside its legacy cardiac-signal platform.
- Operational milestones such as institutional allocations, new custody arrangements, and investor conference appearances have not yet stabilized the share price.
- For deeper detail on valuation and expectations, explore Price Targets, Earnings, and Forecast pages.
- Discover automated trading strategies across thousands of tickers on the Trending AI Robots page.
Streamex Corp. (STEX) Company Overview and Market Position
Streamex Corp. is a technology and digital-asset infrastructure company focused on the tokenization and digitalization of real-world assets. Formerly known as BioSig Technologies, the company rebranded in September 2025 as it repositioned around bringing traditional commodities on-chain through regulated, yield-bearing financial instruments. Its flagship offering, GLDY, provides exposure to physical gold through a liquid structure that incorporates a yield component. The company also maintains its legacy PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures. Headquartered in Winter Park, Florida, Streamex trades on the Nasdaq Capital Market and is closely watched by investors as a small-cap, early-stage play on the intersection of commodities, tokenization, and digital-asset infrastructure.
Streamex Corp. (STEX) Stock Price Performance: Last 30 Days vs. Quarter
Over the 30 days ending at the latest close, Streamex shares declined approximately 47%, falling from a close of about $0.83 in late September to roughly $0.44. The downtrend was broadly consistent rather than a single-event collapse, with the stock grinding lower through most of October before a sharp single-session rebound late in the period partially offset the decline. On a quarterly basis, the stock declined approximately 42%, down from roughly $0.76 three months earlier. This places STEX firmly in a sustained downtrend, with the recent bounce still leaving the shares well below their levels at the start of both the month and the quarter.
What Drove STEX Stock Price in the Last 30 Days
The 30-day decline was driven primarily by sustained selling pressure rather than a single isolated catalyst. Streamex remains a micro-cap company with a limited revenue base and recurring operating losses, and its own filings have flagged uncertainty regarding liquidity and substantial doubt about its ability to continue as a going concern. These disclosures have weighed on investor confidence and contributed to persistent downward momentum in the shares. The stock's elevated volatility, reflected in a beta above 2.0, also amplified price swings in both directions during the period.
Positive operational developments during the window included the announcement of an institutional investment into a strategy built around GLDY, the availability of GLDY shares for custody through CNB Custody, participation in investor conferences, and a monthly yield distribution for the GLDY product. Despite these milestones, they were not sufficient to reverse the broader selling trend, underscoring how dilution concerns and execution uncertainty continued to dominate sentiment.
What Drove STEX Stock Performance Over the Last Quarter
Over the last quarter, Streamex's shares extended a longer-term decline that began well before the most recent 30-day window. The company reported its second-quarter 2026 results in mid-August, disclosing its first revenue from the tokenized gold platform alongside reduced expenses and a narrower net loss. However, the scale of that revenue remains modest, and the company continues to generate substantial net losses. Separately, analyst sentiment cooled as Needham lowered its price target on Streamex from $8 to $4 while maintaining a Buy rating, citing limited incremental adoption of the flagship GLDY product. The broader narrative has been shaped by the gap between an ambitious tokenization roadmap—including the planned GLDC launch and expansion into additional commodities—and the near-term financial reality of a small revenue base and ongoing financing needs.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of automated trading bots from a platform that offers hundreds of AI-driven strategies across thousands of tickers. Only the top-performing and most relevant bots appear in this section, giving traders a focused view of strategies that are currently generating interest. These bots vary widely in strategy, timeframe, and performance metrics, so investors can evaluate approaches ranging from short-term momentum to longer-horizon positioning. For those looking to complement their own research with systematic, data-driven signals, exploring the Trending AI Robots page can be a useful starting point.
STEX Stock Forecast Drivers: What Investors Should Watch Next
Investors monitoring Streamex should watch several factors that could shape the stock's trajectory. The pace of adoption and assets under management for the GLDY product remain central, as does the planned launch of GLDC and any expansion into additional commodities. Financing activity and its dilutive impact are a key risk, given the company's disclosures around liquidity and going-concern uncertainty. Further institutional allocations, custody partnerships, and any progress toward recurring issuance and trading fees will be closely scrutinized. Macro conditions—particularly gold prices and broader risk appetite for small-cap and digital-asset names—also have the potential to influence sentiment. As with all early-stage, high-volatility equities, investors should weigh these factors carefully rather than relying on short-term price moves.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
STEX's Stochastic Oscillator is sitting in oversold zone for 5 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where STEX's RSI Oscillator exited the oversold zone, 40 of 47 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for STEX just turned positive on October 26, 2026. Looking at past instances where STEX's MACD turned positive, the stock continued to rise in 38 of 45 cases over the following month. The odds of a continued upward trend are 84%.
Following a +12.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where STEX advanced for three days, in 217 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on STEX as a result. In 75 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where STEX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for STEX entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. STEX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.271) is normal, around the industry mean (3.120). P/E Ratio (-0.038) is within average values for comparable stocks, (6.734). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.976) among similar stocks. STEX's P/S Ratio (526.316) is very high in comparison to the industry average of (16.899).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STEX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a development stage company which develops medical devices
Industry InvestmentBanksBrokers